FDA Approves Buprenorphine (Probuphine) Implant for Opioid Replacement Therapy

Waismann Method Medical Group in favor of more options in the treatment of opioid dependence and addiction – assuming patients and providers are well-informed LOS ANGELES, May 31, 2016 /PRNewswire/ — Probuphine – a first-of-its-kind buprenorphine implant for use by those dependent on opioids – has received approval from the FDA. The same drug has […]